Continue on TOI App

Here’s what ChatGPT maker Open AI CEO has to say on taking psychedelic drugs that made 8 tech CEOs quit

OpenAI CEO Sam Altman has publicly shared his transformative expe... Read More
Recently, in a viral social media post Austen Allred, the CEO and co-founder of BloomTech claimed that eight Silicon Valley CEOs have resigned from their positions after experimenting with psychedelic drugs. Now, OpenAI CEO, Sam Altman has also revealed that he has been taking psychedelic drugs.

Tired of too many ads?go ad free now
As reported by Business Insider, in a recent interview on the podcast "Life in Seven Songs, Altman revealed how a weekend retreat in Mexico significantly impacted his life and perspective.

Altman described psychedelic drug use as one of the most transformative experiences of his life. He stated that psychedelic experiences can be "incredibly powerful" and that they have personally been life-altering.

For those unaware, Psychedelic drugs have been used across different cultures for spiritual and healing purposes. Recently, there has been a renewed focus on their potential therapeutic applications, particularly in the areas of mental health and self-discovery.

Despite his reputation for confidence and charm, the billionaire revealed that he used to be a "very anxious, unhappy person." "If you had told me that, like, one weekend-long retreat in Mexico was going to significantly change that, I would have said absolutely not," said Altman.

The CEO stated that while he has tried psychedelics at Burning Man(a week-long large-scale desert event, held annually in the western United States), his most profound experiences have been with guided psychedelic retreats. He characterised his experiences at Burning Man as less transformative and rare occurrences.
Tired of too many ads?go ad free now

Altman’s association with psychedelics

Altman's interest in psychedelics extends beyond personal experiences. He has served as the board chairman of Journey Colab, a startup focusing on developing clinical psychedelic drugs for addiction therapy.

The viral post

Austen Allred, the San Francisco-based CEO and co-founder of BloomTech claimed that eight Silicon Valley CEOs have resigned from their positions after experimenting with psychedelic drugs. The post, which has been widely shared on X (formerly Twitter), alleges that these high-ranking executives at prominent tech companies decided to leave their jobs following their experiences with psychedelics. While the post does not provide specific names or companies.

Read the post here

“Of the Silicon Valley founders I know who went on some of the psychedelic self-discovery trips, almost 100% quit their jobs as CEO within a year. Could be random anecdotes, but be careful with that stuff,” posted Allred on X.
Tired of too many ads?
Follow Us On Social Media
end of article
More Trending Stories
UP NEXT
Do Not Sell Or Share My Personal Information